U.S. Markets closed

Cann Group Limited (CNGGF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.59000.0000 (0.00%)
At close: 3:15PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.5900
Open0.5200
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.5900 - 0.5900
52 Week Range0.4600 - 0.5900
Volume954
Avg. Volume2,690
Market Cap129.913M
Beta (5Y Monthly)1.94
PE Ratio (TTM)N/A
EPS (TTM)-0.0280
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • One Cann Group Limited (ASX:CAN) Analyst Just Slashed Their Estimates By A Material 13%
    Simply Wall St.

    One Cann Group Limited (ASX:CAN) Analyst Just Slashed Their Estimates By A Material 13%

    One thing we could say about the covering analyst on Cann Group Limited (ASX:CAN) - they aren't optimistic, having...

  • Aurora Continues To Sell Assets, Places Focus On 'Core Markets'
    Benzinga

    Aurora Continues To Sell Assets, Places Focus On 'Core Markets'

    Aurora Cannabis Inc. (NYSE: ACB) opted to part ways with Australia-based Cann Group.The Canadian cannabis company sold its 12% stake via off-market trades "to a small number of undisclosed buyers" on Friday, Oct 9, after the market closed.Aurora is also selling its assets in Uruguay, per MJ Biz Daily. Alejandro Antalich, the CEO overseeing the company's South American operations, exited the company, the report continued.Both developments come on the heels of Aurora's fourth-quarter earnings report, which was released Monday.During the last fiscal year, the company lost over CA$3.3 billion ($2.5 billion).In addition, its impairment loss amounted to CA$37.2 million ($28.2 million) on its Cann Group position for the fiscal year. In the last year, the impairment charge was CA$18.2 million.Aurora spokeswoman Michelle Lefler told the cannabis business news outlet that they "continue to see growth potential in this important market and will maintain active relationships with key distribution partners to enhance the availability of Aurora's portfolio of leading, high-quality medical cannabis."As a part of its "business transformation plan," executive chair Michael Singer recently noted that the company has been "building the infrastructure and capabilities necessary for a successful and diversified business."Singer was appointed to the role after serving as the company's interim CEO for over six months.Lefler further explained that Aurora's primary focus is on its "core markets," including the medical and recreational market in Canada, the development of international medical markets, and the CBD market in the U.S. on which the company debuted in May.Courtesy imageSee more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * Cannabis Movers & Shakers: Aurora, One World Pharma * Aurora Cannabis Touts 'Business Transformation Plan,' Confirms New CEO And Financial Update(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Cann Group (ASX:CAN) Shareholders Have Enjoyed A 70% Share Price Gain
    Simply Wall St.

    Cann Group (ASX:CAN) Shareholders Have Enjoyed A 70% Share Price Gain

    Cann Group Limited (ASX:CAN) shareholders might be concerned after seeing the share price drop 15% in the last month...